A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Economist: Russia authorizing use of patented inventions from US, 'unfriendly' nations without compensation shows intellectual property is another casualty of war; new law hurts pharmaceutical R&D, as most foreign drugmakers won't launch trials in Russia
Published:
June 24, 2022
by The Economist
|
Labcorp collaborating with HealthVerity to expand Labcorp’s drug development, clinical trial programs; partnership gives Labcorp access to HIPAA-compliant data from HealthVerity’s database of health care, consumer data
Published:
June 24, 2022
by ENP Newswire
|
McKesson and HCA Healthcare form oncology research JV to expand clinical research, accelerate drug development, increase availability and access to clinical trials in underserved communities; McKesson to own 51% of JV, have operating control
Published:
June 24, 2022
by Business Wire
|
Plus Therapeutics partners with Biocept to use Biocept’s CNSide cerebrospinal fluid assay in ReSPECT-LM Phase 1/2a clinical trial of injectable Rhenium-186 nanoLiposome to treat leptomeningeal metastases, a cancer of brain, spinal cord membranes
Published:
June 23, 2022
by GlobeNewswire
|
Eli Lilly supplying Aveo Oncology with Erbitux cetuximab for North American clinical trial evaluating Aveo’s ficlatuzumab with cetuximab to treat metastatic head, neck squamous cell carcinoma; Merck KGaA providing cetuximab outside of US, Canada
Published:
June 23, 2022
by GlobeNewswire
|
Ask us about our R&D/Patents market view
Trending Chart
Interactive chart with headline count